challenges facing new pathway inhibitor treatments in prostate cancer
Published 1 year ago • 42 plays • Length 1:10Download video MP4
Download video MP3
Similar videos
-
2:09
current perspectives from clinical trials using parp inhibitors for prostate cancer
-
2:16
challenges for prostate cancer: overdiagnosis and unnecessary treatment
-
1:35
parp inhibitors for the treatment of metastic castration-resistant prostate cancer
-
1:00:07
pi3k/akt pathway inhibition for the treatment of metastatic castrate-resistant prostate cancer
-
30:15
what's new in prostate cancer treatment? by heather cheng, md, phd
-
2:32
arasens: will combining different treatments improve prostate cancer survival?
-
45:15
treatment updates for advanced prostate cancer – 2023 zero prostate cancer summit
-
4:51
living with prostate cancer: challenges
-
1:06
combining tkis with checkpoint inhibitors for prostate cancer – is this the way forward?
-
16:03
burning questions and controversies in the management of advanced prostate cancer patients
-
33:19
castration resistant prostate cancer - developments and challenges from 2020
-
39:02
systemic therapies for the treatment of advanced prostate cancer
-
1:23
treatment options for small cell prostate cancer
-
0:54
what are the early warning signs of prostate problems?
-
42:08
prostate cancer: clinical guidelines, novel therapies, and therapeutic uncertainty
-
53:36
prostate cancer treatment overview: what's changing - summit 2021
-
26:30
prostate cancer : treatments beyond chemotherapy and future directions
-
0:13
advanced prostate cancer simplified
-
49:20
changing the treatment story with hormonal therapy in prostate cancer